DianaRKerwinMD

Dementia

Director, Texas Alzheimer's and Memory, Presbyterian Hospital Assistant Professor, Department of Neurology and Neurotherapeutics, University of Texas Southwestern

Join to view full profile

Dr. Kerwin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kerwin's full profile

Already have an account?

Office
8198 Walnut Hill Lane
Jackson 100
Dallas, TX 75231
Phone+1 214-345-4449

Fax+1 214-345-1238

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1997 - 1999
Loyola University Medical CenterInternship, Internal Medicine, 1996 - 1997
Medical College of WisconsinClass of 1996

Certifications & Licensure

TX State Medical License 2013 - 2026
WI State Medical License 2002 - 2025
CA State Medical License 2018 - 2024
IL State Medical License 1999 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Geriatric Medicine

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Super Doctor SuperDoctors.com

Clinical Trials

Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease Start of enrollment: 2008 Sep 01
Withdrawn
Phase 3
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Start of enrollment: 2015 Jul 01
Completed
Phase 1
Flortaucipir PET Imaging in Subjects With FTD Start of enrollment: 2017 Apr 11
Completed
Phase 1
Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease
No longer available
Join now to see all

Publications & Presentations

PubMed

13 citations
The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Al...
Richard C Mohs, Douglas Beauregard, John Dwyer, Jennifer Gaudioso, Jason Bork
Alzheimer's & Dementia. 2024-04-01
1 citations
Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD).
Amanda N Szabo-Reed, Tristyn Hall, Eric D Vidoni, Angela Van Sciver, Monica Sewell
Alzheimer's & Dementia. 2023-10-14
40 citations
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.
Sheila Seleri Assunção, Reisa A Sperling, Craig Ritchie, Diana R Kerwin, Paul S Aisen
Alzheimer's Research & Therapy. 2022-04-19

Press Mentions

Alzheimer's Disease Treatment Offers Hope to Patients in the Early Stages of DiseaseAugust 19th, 2024
Frontotemporal Dementia: What You Need to Know About the Condition Affecting Bruce WillisMarch 6th, 2023
What 42 Previously Unknown Genes May Tell Us About Treating Alzheimer’s DiseaseApril 25th, 2022
Join now to see all